Skip to main content

Tweets

What's it like to have #RA? PATTY "To find patients or doctors who can talk intelligently about RA is a welcomed relief. However, I prefer that those around me not know about me and my RA. I hope they don’t notice the changes in my hands or shoes or that I cannot wear my usual https://t.co/OQbXJrcyPp
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
After hours EHR catchup has been coined "Pajama time" by residents & physicians & contributes to burnout. Survey 9,731 YR 2 Family Med residents- spend 3+ hrs/d after wk on ambulatory EHRs. Pajama time assoc w/ less knowledge, professional satisfaction, more burnout. https://t.co/QSR7VM2T7u
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
Brepocitinib in Dermatomyositis The NEJM reports that brepocitinib, an oral TYK2–JAK1 inhibitor, was studied in a phase 3 trial of refractory dermatomyositis (DM) patients and shown to have significant benefits at the higher dose. https://t.co/YNxrVTIubb https://t.co/uFY3kMOvui
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
AFFINITY Study - Combination Biologic Therapy in PsA A pilot trial assessed the efficacy and safety of the guselkumab+golimumab (COMBO) combination versus GUS monotherapy in active PsA (failing a prior tumor necrosis factor inhibitor (TNFi-IR) and showed superiority in ACR 50 https://t.co/f2CB8FnZMB
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
FDA has issued a drug safety warning for avacopan (Tavneos), dentifying 76 cases of drug-induced liver injury, including 7 cases of rare vanishing bile duct syndrome (VBDS). There were 8 deaths https://t.co/WkBhs1rNpf https://t.co/ZXdHsAJUOQ
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
The Mucosal Hypothesis of Rheumatoid Arthritis. Dr. Kristin Demoruelle In this https://t.co/4UQlqwujiR 2026 podcast, Dr. Kristin Demoruelle explores the mucosal origins of RA and its implications. 🎧 Listen here: https://t.co/QxldIpYQC8 #Rheumatology #Autoimmunity #RNL2026 https://t.co/nz2dbwll14
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
DERM on RheumNow PODCAST (March 2026) https://t.co/OGl34cH6z5 https://t.co/l7v1Xktl8r
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
Moral Distress (3.27.2026) Dr. Jack Cush reviews the journal reports and news from RheumNow. This week we discuss moral distress, FM in PsA, Lyme Vax is back & hidden but tangible benefits of the MDHAQ. https://t.co/LdNcsUcHc2 https://t.co/tRYeDhQ3hC
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
AXIS is an Intl prospective study of 409 psoriatic arthritis pts - found Axial involvement in 27.4% of pts. Axial PsA signif younger (45 vs 47.6 yrs) , male (56% vs 51.5%), more B27 positivity (22% vs 11%), inflammatory back pain (75% vs 43%), & ^CRP (53% vs 37%) https://t.co/XY5pf4BNNm
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
19 yr old male is Dx w/ Stills Dz (Fever 104F, pleuritis, organomegaly, WBC 24k, ESR 98, CRP 11 mg/L) - what drug do you prescribe first?

Dr. John Cush @RheumNow ( View Tweet )

2 months 3 weeks ago
Portugese multicentre retrospective of 748 adults with JIA (age 28 yrs; Dz duration 21 yrs). Oligoarticular JIA was the most common subtype (29.9%). HTN (9%), psychiatric dz (8%), & osteoporosis (5%) were most prevalent comorbidities. bDMARD use reduced risk of psych Dz https://t.co/xCrTDxirlj
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
Psychiatrists have the highest Medicare opt-out rate (8% vs 1.2% MDs vs <3% Rheum), leading to a critical shortage of psychiatrists and more antipsychotic management to APRNs and PAs over the last decade. APPs Handle 40% of Antipsychotic Scripts https://t.co/wWnFcnXpRa https://t.co/WSQBEzvxgK
Dr. John Cush @RheumNow ( View Tweet )
2 months 3 weeks ago
×